Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Recruiting · NCT07573735 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Not stated | 2026-06-11 | NCT07573735 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhongda Hospital | 46 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongda Hospital, Southeast University | Nanjing | China | 4 |